Recent Posts

Re: Risk factors of tuberculosis (TB) by auntiebiotic
[November 10, 2016, 15:46:01 PM]

Re: A to Z of tuberculosis (Letter B) by auntiebiotic
[November 08, 2016, 21:44:13 PM]

A to Z of tuberculosis (Letter A) by auntiebiotic
[November 08, 2016, 21:32:38 PM]

Foods that help immune system by auntiebiotic
[November 08, 2016, 20:06:05 PM]

Cats and TB (Tuberculosis) by auntiebiotic
[November 08, 2016, 18:37:25 PM]

User Info

Welcome, Guest. Please login or register.


Board Stats

  • stats Total Members: 2
  • stats Total Posts: 57
  • stats Total Topics: 53
  • stats Total Categories: 6
  • stats Total Boards: 17
  • stats Most Online: 23

  • averages Average Posts: 0
  • averages Average Topics: 0
  • averages Average Members: 0
  • averages Average Online: 1

* Stat

Author Topic: BCG Vaccine (Bacillus Calmette-Guerin)  (Read 88 times)



  • Administrator
  • Jr. Member
  • *****
  • Posts: 57
  • Karma: +0/-0
    • View Profile
BCG Vaccine (Bacillus Calmette-Guerin)
« on: November 01, 2016, 12:03:19 PM »

The BCG vaccine (Bacillus Calmette-Guerin) was introduced into the UK in 1953. The vaccine has modified small amounts of the TB bacterium. The injection is usually given into the left upper arm. The vaccine is thought to give more than 70% protection against TB. So, although it is a good vaccine, it does not guarantee protection against TB. Some people still develop TB even if they have had the BCG vaccine.

After having the injection, it is normal to develop a red lump over the injection site. This may increase in size for a few weeks before settling down into a scab. It is not necessary to cover the site with a bandage unless it oozes. If this happens, use a dressing just until the oozing stops. After several weeks the scab goes and you are left with a small scar.

BCG, or bacille Calmette-GuerinBCG, or bacille Calmette-Guerin, is a vaccine for tuberculosis (TB) disease. BCG is used in many countries with a high
prevalence of TB to prevent childhood tuberculous meningitis and miliary disease. However, BCG is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccines potential interference with tuberculin skin test reactivity. The BCG vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert. Recommendations

BCG vaccination should only be considered for children who have a negative tuberculin skin test and who are continually exposed, and cannot be separated from, adults who

Are untreated or ineffectively treated for TB disease (if the child cannot be   given long-term treatment for infection); or
Have TB caused by strains resistant to isoniazid and rifampin.

Health Care Workers. BCG vaccination of health care workers should be considered on an individual basis in settings in which

    A high percentage of TB patients are infected with M. tuberculosis strains resistant to both isoniazid and rifampin;
    There is ongoing transmission of such drug-resistant M. tuberculosis strains to health care workers and subsequent infection is likely; or
    Comprehensive TB infection-control precautions have been implemented but have not been successful.

Health Care Workers considered for BCG vaccination should be counseled regarding the risks and benefits associated with both BCG vaccination and treatment of latent TB infection (LTBI).

Immunosuppressed Persons. BCG vaccination should not be given to persons who are immunosuppressed (e.g., persons who are HIV-infected) or who are likely to become immunocompromised (e.g., persons who are candidates for organ transplant).

Pregnant Women
BCG vaccination should not be given during pregnancy. Even though no harmful effects of BCG vaccination on the fetus have been observed, further studies are needed to prove its safety.

Testing for TB in BCG-Vaccinated Persons
Many foreign-born persons have been BCG-vaccinated. BCG vaccination may cause a positive reaction to the tuberculin skin test (TST), which may complicate decisions about prescribing treatment.

Despite this potential for BCG to interfere with test results, the TST and the QuantiFERON-TB Gold test (QFT-G) are not contraindicated for persons who have been vaccinated with BCG.

The presence or size of a TST reaction in these persons does not predict whether BCG will provide any protection against TB disease.

Furthermore, the size of a TST reaction in a BCG-vaccinated person is not a factor in determining whether the reaction is caused by LTBI or the prior BCG vaccination.
« Last Edit: November 08, 2016, 16:09:50 PM by auntiebiotic »


SMF spam blocked by CleanTalk